‘Kyprolis’ receives health insurance benefits with RSA from 5 February

Published: 2018-02-02 16:29:00
Updated: 2018-02-02 14:31:43

‘Kyprolis Inj,’ an Amgen’s multiple myeloma therapy, has passed the Health Insurance Policy Deliberation Committee

Along with enforcement of the life-prolonging treatment, the government will also carry out other plans, such as a demo project for health insurance benefits and revise of health in...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.